3.49
price down icon2.51%   -0.09
after-market After Hours: 3.45 -0.04 -1.15%
loading
Bioage Labs Inc stock is traded at $3.49, with a volume of 380.87K. It is down -2.51% in the last 24 hours and down -24.62% over the past month. Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
See More
Previous Close:
$3.58
Open:
$3.55
24h Volume:
380.87K
Relative Volume:
1.53
Market Cap:
$128.34M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.53%
1M Performance:
-24.62%
6M Performance:
-82.31%
1Y Performance:
+0.00%
1-Day Range:
Value
$3.47
$3.58
1-Week Range:
Value
$3.47
$4.04
52-Week Range:
Value
$3.47
$26.62

Bioage Labs Inc Stock (BIOA) Company Profile

Name
Name
Bioage Labs Inc
Name
Phone
510-806-1445
Name
Address
1445A SOUTH 50TH STREET, RICHMOND
Name
Employee
64
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
BIOA's Discussions on Twitter

Compare BIOA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
BIOA
Bioage Labs Inc
3.49 128.34M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.50 72.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.98 47.08B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.16 45.99B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.29 17.52B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.26 13.78B 2.76B 1.11B 898.10M 22.77

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Initiated William Blair Mkt Perform
Dec-10-24 Downgrade Morgan Stanley Overweight → Underweight
Dec-09-24 Downgrade Citigroup Buy → Neutral
Dec-09-24 Downgrade Jefferies Buy → Hold
Oct-21-24 Initiated Citigroup Buy
Oct-21-24 Initiated Jefferies Buy
Oct-21-24 Initiated Morgan Stanley Overweight
View All

Bioage Labs Inc Stock (BIOA) Latest News

pulisher
Mar 26, 2025

Several Insiders Invested In BioAge Labs Flagging Positive News - Yahoo Finance

Mar 26, 2025
pulisher
Mar 23, 2025

Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk - TipRanks

Mar 23, 2025
pulisher
Mar 23, 2025

BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects - TipRanks

Mar 23, 2025
pulisher
Mar 20, 2025

BioAge Labs Inc. (BIOA) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

BioAge Labs, Inc. Advances NLRP3 Inhibitor BGE-102 and Forms Strategic Collaborations with Novartis and Lilly for Metabolic Diseases - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the - Bluefield Daily Telegraph

Mar 20, 2025
pulisher
Mar 20, 2025

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024 - TradingView

Mar 20, 2025
pulisher
Mar 10, 2025

Final Deadline for the BioAge Labs, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsBIOA - The Malaysian Reserve

Mar 10, 2025
pulisher
Mar 10, 2025

BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire

Mar 10, 2025
pulisher
Mar 10, 2025

BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors - Bluefield Daily Telegraph

Mar 10, 2025
pulisher
Mar 10, 2025

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Markets Insider

Mar 10, 2025
pulisher
Mar 10, 2025

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire

Mar 10, 2025
pulisher
Mar 10, 2025

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi ... - Bluefield Daily Telegraph

Mar 10, 2025
pulisher
Mar 10, 2025

2025-03-10 | Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Mar 10, 2025
pulisher
Mar 10, 2025

DEADLINE ALERT for REGN and BIOA: The Law Offices of Frank - GlobeNewswire

Mar 10, 2025
pulisher
Mar 10, 2025

BIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged - GlobeNewswire

Mar 10, 2025
pulisher
Mar 10, 2025

BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - themalaysianreserve.com

Mar 10, 2025
pulisher
Mar 10, 2025

Investors in BioAge Labs, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your RightsBIOA - GuruFocus.com

Mar 10, 2025
pulisher
Mar 10, 2025

BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire

Mar 10, 2025
pulisher
Mar 09, 2025

2025-03-09 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. LawsuitBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Mar 09, 2025
pulisher
Mar 09, 2025

Class Action Filed Against BioAge Labs, Inc. (BIOA)March 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

BIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit | StreetInsider.com - Financial Content

Mar 08, 2025
pulisher
Mar 08, 2025

BIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - GlobeNewswire Inc.

Mar 08, 2025
pulisher
Mar 07, 2025

BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Act - The National Law Review

Mar 07, 2025
pulisher
Mar 07, 2025

BIOA Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge ... - Bluefield Daily Telegraph

Mar 07, 2025
pulisher
Mar 07, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

BIOA DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors ... - The Bakersfield Californian

Mar 07, 2025
pulisher
Mar 07, 2025

Deadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire

Mar 07, 2025
pulisher
Mar 07, 2025

BIOA Deadline: Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Joplin Globe

Mar 07, 2025
pulisher
Mar 07, 2025

Cautious Outlook on BioAge Labs, Inc. Amid Program Discontinuation and Development Risks - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Faruqi & Faruqi Reminds BioAge Investors of the Pending - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Mar 07, 2025
pulisher
Mar 06, 2025

The Gross Law Firm Notifies Shareholders of BioAge Labs, - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

BIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit - PR Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

INVESTOR DEADLINE MONDAY: BioAge Labs, Inc. Investors with Subst - GuruFocus.com

Mar 06, 2025
pulisher
Mar 06, 2025

INVESTOR DEADLINE MONDAY: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBIOA - PR Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

2025-03-06 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. LawsuitBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Mar 06, 2025
pulisher
Mar 06, 2025

The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

BioAge Labs, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

BioAge Labs, Inc. (NASDAQ: BIOA) Investor Notice: Deadline in Lawsuit on March 10, 2025 - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

BioAge Labs, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March - The Bakersfield Californian

Mar 05, 2025
pulisher
Mar 05, 2025

BIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - The Malaysian Reserve

Mar 05, 2025
pulisher
Mar 05, 2025

Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.

Mar 05, 2025

Bioage Labs Inc Stock (BIOA) Financials Data

There is no financial data for Bioage Labs Inc (BIOA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.77
price up icon 4.06%
$32.65
price up icon 0.37%
$97.42
price down icon 0.52%
$8.66
price up icon 0.70%
$108.31
price up icon 1.22%
$312.26
price up icon 1.75%
Cap:     |  Volume (24h):